Obstructive Jaundice
Find comprehensive information on obstructive jaundice, including clinical documentation tips, ICD-10 codes (R17), medical coding guidelines, biliary obstruction diagnosis, symptoms like hyperbilirubinemia and cholestasis, and treatment options. Learn about the causes of obstructive jaundice such as gallstones, pancreatic cancer, and bile duct tumors. This resource offers essential guidance for healthcare professionals on accurately documenting and coding obstructive jaundice cases for optimal reimbursement and patient care. Explore relevant medical terminology, diagnostic procedures, and clinical management strategies for this hepatobiliary condition.
Blockage of bile flow from the liver to the intestines, leading to bilirubin buildup.
Yellow skin (jaundice), dark urine, pale stools, itchy skin, abdominal pain.
Gallstones, tumors (pancreatic, liver, bile duct), inflammation, strictures.
ICD-10 Code Families
Complete code families applicable to K83.1
When to use each related code
| Description | When to use |
|---|---|
| Obstructive Jaundice | Bile flow blockage. Use when jaundice is due to gallstones, tumors, or strictures. |
| Hepatocellular Jaundice | Liver cell dysfunction causing jaundice. Use for hepatitis, cirrhosis, or liver failure. Consider liver function tests. |
| Hemolytic Jaundice | Excessive red blood cell breakdown. Use when jaundice is from hemolysis, e.g., sickle cell, G6PD deficiency. |
Best-practice checklist
- ✓Obstructive jaundice diagnosis: Document biliary obstruction evidence.
- ✓Jaundice: Specify onset, duration, and associated symptoms (e.g., pain, pruritus).
- ✓Document location and nature of obstruction (e.g., stone, tumor).
- ✓Diagnostic tests: Results of liver function tests, imaging studies (US, CT, MRCP).
- ✓Treatment plan: Detail procedures or medications for relieving obstruction.
Common pitfalls to avoid
Coding obstructive jaundice without documenting the underlying cause (e.g., choledocholithiasis, tumor) leads to inaccurate coding and DRG assignment.
Failing to capture comorbidities like acute cholangitis or acute pancreatitis complicating obstructive jaundice impacts severity and reimbursement.
Coding obstructive jaundice based on symptoms alone without confirmatory diagnostic tests (e.g., imaging, LFTs) raises audit risks and claim denials.
Best-practice tips
- 01Document precise jaundice onset, duration, characteristics for accurate ICD-10 coding (R17).
- 02Detailed HPI crucial for biliary obstruction diagnosis, supporting medical necessity, avoiding denials.
- 03Order appropriate imaging (ultrasound, CT) per clinical guidelines to confirm obstruction, justify procedures.
- 04Correlate lab results (bilirubin, ALP, GGT) with imaging findings for complete obstructive jaundice workup.
- 05Timely specialist consults (GI, surgery) optimize patient care, improve CDI, ensure compliance.
Step-by-step checklist
- 1
Verify elevated bilirubin: conjugated >2 mg/dL
- 2
Review imaging (ultrasound, CT, MRCP): biliary dilation?
- 3
Check LFTs: elevated ALP, GGT, AST, ALT patterns?
- 4
Assess for abdominal pain, pale stools, dark urine
Ready-to-paste narrative
Patient presents with obstructive jaundice, characterized by hyperbilirubinemia, predominantly conjugated. Clinical manifestations include yellowing of the skin and sclera (icterus), dark urine, and clay-colored stools. Pruritus is also reported. Possible etiologies under consideration include choledocholithiasis, biliary stricture, pancreatic head mass, and cholangiocarcinoma. Differential diagnosis includes pre-hepatic causes of jaundice such as hemolysis and hepatic causes like hepatitis. Initial laboratory evaluation reveals elevated total and direct bilirubin, elevated alkaline phosphatase, and elevated gamma-glutamyl transferase (GGT). Liver function tests, including aspartate aminotransferase (AST) and alanine aminotransferase (ALT), may be elevated. Abdominal ultrasound is ordered to assess biliary duct dilation and identify potential obstructing masses. Further imaging with magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP) may be indicated for definitive diagnosis and potential therapeutic intervention. Treatment plan is dependent on the underlying cause of the obstruction and may include endoscopic or surgical removal of the obstruction, biliary stenting, or percutaneous transhepatic cholangiography (PTC) for drainage. Patient education regarding the condition, diagnostic procedures, and treatment options was provided. Follow-up appointment scheduled to review imaging results and determine further management. ICD-10 code R17 is considered, with further specification based on the identified cause of obstruction. Medical billing will reflect the diagnostic procedures and therapeutic interventions performed.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.